Framingham Heart Study Adds Proteomics, Pens CRADA with BG Medicine for Biomarker Discovery
March 19, 2009
Framingham Heart Study Adds Proteomics, Pens CRADA with BG Medicine for Biomarker Discovery
The collaboration is the first cooperative research-and-development agreement between FHS and a commercial partner in the study's 60-year history. It also marks the first time the study has ever used proteomics.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- BG Medicine Inks CRADA with NHLBI, BU to ID Heart Disease Markers from Framingham Study
March 18, 2009 / Pharmacogenomics Reporter - Unable to Find Necessary Additional Funding, Vermillion Files for Chapter 11 Bankruptcy
April 2, 2009 / ProteoMonitor - NHLBI to Start Third Proteomics Program
March 26, 2009 / Genome Technology - NHLBI Set to Start Third Major Proteomics Program
March 5, 2009 / ProteoMonitor - NIH Funding for Proteomics Research Fell in FY 2008
February 24, 2009 / Genome Technology